Ligand Pharmaceuticals, Inc. (LGND)
299.00
+5.19
(+1.77%)
USD |
NASDAQ |
Nov 18, 16:00
299.00
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals Price to Book Value : 6.218 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 6.110 |
| November 16, 2026 | 6.274 |
| November 13, 2026 | 6.422 |
| November 12, 2026 | 6.577 |
| November 11, 2026 | 6.589 |
| November 10, 2026 | 6.533 |
| November 09, 2026 | 6.533 |
| November 06, 2026 | 6.368 |
| November 05, 2026 | 6.218 |
| November 04, 2026 | 6.574 |
| November 03, 2026 | 6.52 |
| November 02, 2026 | 6.385 |
| October 30, 2026 | 6.712 |
| October 29, 2026 | 6.599 |
| October 28, 2026 | 6.629 |
| October 27, 2026 | 6.483 |
| October 26, 2026 | 6.412 |
| October 23, 2026 | 6.312 |
| October 22, 2026 | 6.402 |
| October 21, 2026 | 6.546 |
| October 20, 2026 | 6.372 |
| October 19, 2026 | 6.182 |
| October 16, 2026 | 6.146 |
| October 15, 2026 | 6.208 |
| October 14, 2026 | 6.135 |
| Date | Value |
|---|---|
| October 13, 2026 | 6.312 |
| October 12, 2026 | 6.470 |
| October 09, 2026 | 6.276 |
| October 08, 2026 | 6.135 |
| October 07, 2026 | 6.099 |
| October 06, 2026 | 6.175 |
| October 05, 2026 | 6.380 |
| October 02, 2026 | 6.300 |
| October 01, 2026 | 6.296 |
| September 30, 2026 | 6.496 |
| September 29, 2026 | 6.390 |
| September 28, 2026 | 6.467 |
| September 25, 2026 | 6.208 |
| September 24, 2026 | 6.157 |
| September 23, 2026 | 6.144 |
| September 22, 2026 | 6.146 |
| September 21, 2026 | 5.972 |
| September 18, 2026 | 5.837 |
| September 17, 2026 | 5.862 |
| September 16, 2026 | 5.666 |
| September 15, 2026 | 5.703 |
| September 14, 2026 | 5.778 |
| September 11, 2026 | 5.857 |
| September 10, 2026 | 5.955 |
| September 09, 2026 | 5.931 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 8.089 |
| Eli Lilly & Co. | 32.31 |
| Bristol Myers Squibb Co. | 5.203 |
| Xeris Biopharma Holdings, Inc. | 63.58 |
| LENZ Therapeutics, Inc. | 0.5237 |
Price to Book Value Related Metrics
| PE Ratio | 133.38 |
| PS Ratio | 24.39 |
| PEG Ratio | 16.89 |
| Price to Free Cash Flow | 107.71 |
| Price | 299.00 |
| Earnings Yield | 0.75% |
| Market Cap | 5.980B |
| PEGY Ratio | 16.89 |
| Operating PE Ratio | 169.57 |
| Normalized PE Ratio | 80.74 |